Adherence to GLP-1s better than earlier reported Source: Marshall, LZ et al Trends in 1-year persistence and adherence among initiators of high-potency, weight lossindicated glucagon-like peptide 1 receptor agonists, J Man Care Pharm February 27, 2026 Multiple studies have reported low adherence to GLP-1 medications to treat obesity, and some have cited this as a reason why employers should not cover these medications
Rich in growth factors such as insulin-like growth factor 1 (IGF-1) and transforming growth factor beta (TGF-beta), colostrum supports the growth and repair of the intestinal lining, aiding in the prevention of leaky gut syndrome and other gastrointestinal issues
Programme data have reported, for example, higher mean weight loss at 72 weeks with a GIP/GLP-1 regimen than with some GLP-1-only arms at different time pointscontext, population, and rescue/adherence rules all matter
Both are used based on strong preclinical evidence, favorable safety data, and growing clinical experience
6 days | | Bioavailability | High, no absorption enhancer | approx